Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma

類似資料

• Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
  著者:: Borch, Troels Holz, 等
  出版事項: (2020)
• T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients
  著者:: Borch, Troels Holz, 等
  出版事項: (2014)
• PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine
  著者:: Munir Ahmad, Shamaila, 等
  出版事項: (2016)
• CTLA-4 blockade boosts the expansion of tumor-reactive CD8(+) tumor-infiltrating lymphocytes in ovarian cancer
  著者:: Friese, Christina, 等
  出版事項: (2020)
• Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer
  著者:: Kverneland, Anders Handrup, 等
  出版事項: (2020)